Literature DB >> 23567008

Blood glucose measurement in the intensive care unit: what is the best method?

Huong T Le1, Neil S Harris, Abby J Estilong, Arvid Olson, Mark J Rice.   

Abstract

Abnormal glucose measurements are common among intensive care unit (ICU) patients for numerous reasons and hypoglycemia is especially dangerous because these patients are often sedated and unable to relate the associated symptoms. Additionally, wide swings in blood glucose have been closely tied to increased mortality. Therefore, accurate and timely glucose measurement in this population is critical. Clinicians have several choices available to assess blood glucose values in the ICU, including central laboratory devices, blood gas analyzers, and point-of-care meters. In this review, the method of glucose measurement will be reviewed for each device, and the important characteristics, including accuracy, cost, speed of result, and sample volume, will be reviewed, specifically as these are used in the ICU environment. Following evaluation of the individual measurement devices and after considering the many features of each, recommendations are made for optimal ICU glucose determination.
© 2013 Diabetes Technology Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23567008      PMCID: PMC3737651          DOI: 10.1177/193229681300700226

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  47 in total

1.  Effects of different hematocrit levels on glucose measurements with handheld meters for point-of-care testing.

Authors:  Z Tang; J H Lee; R F Louie; G J Kost
Journal:  Arch Pathol Lab Med       Date:  2000-08       Impact factor: 5.534

Review 2.  Applying the right statistics: analyses of measurement studies.

Authors:  J M Bland; D G Altman
Journal:  Ultrasound Obstet Gynecol       Date:  2003-07       Impact factor: 7.299

3.  Accuracy evaluation of a new glucometer with automated hematocrit measurement and correction.

Authors:  Lokinendi V Rao; Felice Jakubiak; James S Sidwell; James W Winkelman; Michael L Snyder
Journal:  Clin Chim Acta       Date:  2005-03-31       Impact factor: 3.786

4.  Standards of medical care in diabetes--2008.

Authors: 
Journal:  Diabetes Care       Date:  2008-01       Impact factor: 19.112

5.  Positive interference of icodextrin metabolites in some enzymatic glucose methods.

Authors:  W Janssen; G Harff; M Caers; A Schellekens
Journal:  Clin Chem       Date:  1998-11       Impact factor: 8.327

6.  Evaluating stat testing options in an academic health center: therapeutic turnaround time and staff satisfaction.

Authors:  M L Kilgore; S J Steindel; J A Smith
Journal:  Clin Chem       Date:  1998-08       Impact factor: 8.327

7.  Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.

Authors:  David B Sacks; Mark Arnold; George L Bakris; David E Bruns; Andrea Rita Horvath; M Sue Kirkman; Ake Lernmark; Boyd E Metzger; David M Nathan
Journal:  Diabetes Care       Date:  2011-06       Impact factor: 19.112

8.  Comparison of the accuracy of the HemoCue glucose analyzer with the Yellow Springs Instrument glucose oxidase analyzer, particularly in hypoglycemia.

Authors:  Alexander D M Stork; Hans Kemperman; D Willem Erkelens; Thiemo F Veneman
Journal:  Eur J Endocrinol       Date:  2005-08       Impact factor: 6.664

9.  Comparision between bed side testing of blood glucose by glucometer vs centralized testing in a tertiary care hospital.

Authors:  Ayaz Baig; Imran Siddiqui; Abdul Jabbar; Syed Iqbal Azam; Salman Sabir; Shahryar Alam; Farooq Ghani
Journal:  J Ayub Med Coll Abbottabad       Date:  2007 Jul-Sep

10.  Evaluation of the blood gas analyzer Gem PREMIER 3000.

Authors:  Bénédicte Bénéteau-Burnat; Marie-Chantal Bocque; Anne Lorin; Catherine Martin; Michel Vaubourdolle
Journal:  Clin Chem Lab Med       Date:  2004-01       Impact factor: 3.694

View more
  8 in total

1.  Analysis: New point-of-care blood glucose monitoring system for the hospital demonstrates satisfactory analytical accuracy using blood from critically ill patients--an important step toward improved blood glucose control in the hospital.

Authors:  Jeffrey I Joseph
Journal:  J Diabetes Sci Technol       Date:  2013-09-01

2.  Impact of point-of-care creatinine monitoring on early detection of acute kidney injury in critical illness.

Authors:  Kaori Takaori; Shigehiko Uchino; Masanori Takinami
Journal:  J Nephrol       Date:  2019-09-11       Impact factor: 3.902

3.  Evaluation of CareSens POCT Devices for Glucose Testing in the Routine Hospital Setting.

Authors:  Kagan Huysal; Yasemin U Budak; Hakan Demirci; Mehmet Ali Önelge
Journal:  J Clin Diagn Res       Date:  2015-10-01

Review 4.  Dual-hormone artificial pancreas for management of type 1 diabetes: Recent progress and future directions.

Authors:  Marco Infante; David A Baidal; Michael R Rickels; Andrea Fabbri; Jay S Skyler; Rodolfo Alejandro; Camillo Ricordi
Journal:  Artif Organs       Date:  2021-07-15       Impact factor: 2.663

5.  Prolonged bilateral reactive miosis as a symptom of severe insulin intoxication.

Authors:  Ilse Gradwohl-Matis; Jakob Pann; Christian A Schmittinger; Andreas Brunauer; Daniel Dankl; Martin W Duenser
Journal:  Am J Case Rep       Date:  2015-01-03

6.  Validity of bedside blood glucose measurement in critically ill patients with intensive insulin therapy.

Authors:  Ata Mahmoodpoor; Hadi Hamishehkar; Kamran Shadvar; Sarvin Sanaie; Afshin Iranpour; Vahid Fattahi
Journal:  Indian J Crit Care Med       Date:  2016-11

7.  Comparison of Space Glucose Control and Routine Glucose Management Protocol for Glycemic Control in Critically Ill Patients: A Prospective, Randomized Clinical Study.

Authors:  Biao Xu; Wei Jiang; Chun-Yao Wang; Li Weng; Xiao-Yun Hu; Jin-Min Peng; Bin Du
Journal:  Chin Med J (Engl)       Date:  2017-09-05       Impact factor: 2.628

Review 8.  The Oral Glucose Tolerance Test-Is It Time for a Change?-A Literature Review with an Emphasis on Pregnancy.

Authors:  Delia Bogdanet; Paula O'Shea; Claire Lyons; Amir Shafat; Fidelma Dunne
Journal:  J Clin Med       Date:  2020-10-27       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.